These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 25069861)
1. Epithelial-to-mesenchymal transition (EMT) in intraductal papillary mucinous neoplasm (IPMN) is associated with high tumor grade and adverse outcomes. Lahat G; Lubezky N; Loewenstein S; Nizri E; Gan S; Pasmanik-Chor M; Hayman L; Barazowsky E; Ben-Haim M; Klausner JM Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S750-7. PubMed ID: 25069861 [TBL] [Abstract][Full Text] [Related]
2. Gene expression changes associated with the progression of intraductal papillary mucinous neoplasms. Jury RP; Thibodeau BJ; Fortier LE; Geddes TJ; Ahmed S; Pruetz BL; Farinola MA; Wilson GD Pancreas; 2012 May; 41(4):611-8. PubMed ID: 22273699 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression signatures in intraductal papillary mucinous neoplasm of the pancreas. Lubezky N; Loewenstein S; Ben-Haim M; Brazowski E; Marmor S; Pasmanik-Chor M; Oron-Karni V; Rechavi G; Klausner JM; Lahat G Surgery; 2013 May; 153(5):663-72. PubMed ID: 23305591 [TBL] [Abstract][Full Text] [Related]
4. Epithelial-mesenchymal transition and mesenchymal-epithelial transition via regulation of ZEB-1 and ZEB-2 expression in pancreatic cancer. Kurahara H; Takao S; Maemura K; Mataki Y; Kuwahata T; Maeda K; Ding Q; Sakoda M; Iino S; Ishigami S; Ueno S; Shinchi H; Natsugoe S J Surg Oncol; 2012 Jun; 105(7):655-61. PubMed ID: 22213144 [TBL] [Abstract][Full Text] [Related]
5. Proteomic assessment of markers for malignancy in the mucus of intraductal papillary mucinous neoplasms of the pancreas. Corcos O; Couvelard A; Dargère D; Sauvanet A; Hammel P; Paradis V; Lévy P; Ruszniewski P; Bedossa P Pancreas; 2012 Mar; 41(2):169-74. PubMed ID: 22076567 [TBL] [Abstract][Full Text] [Related]
6. Effect of Twist and Bmi1 on intraductal papillary mucinous neoplasm of the pancreas. Ishikawa D; Shimada M; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Yamada S; Miyake H J Gastroenterol Hepatol; 2014 Dec; 29(12):2032-7. PubMed ID: 24909638 [TBL] [Abstract][Full Text] [Related]
7. Pancreatic intraductal papillary mucinous neoplasm in a patient with Lynch syndrome. Flanagan MR; Jayaraj A; Xiong W; Yeh MM; Raskind WH; Pillarisetty VG World J Gastroenterol; 2015 Mar; 21(9):2820-5. PubMed ID: 25759555 [TBL] [Abstract][Full Text] [Related]
8. Micro RNA-373 is down-regulated in pancreatic cancer and inhibits cancer cell invasion. Nakata K; Ohuchida K; Mizumoto K; Aishima S; Oda Y; Nagai E; Tanaka M Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S564-74. PubMed ID: 24748127 [TBL] [Abstract][Full Text] [Related]
9. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer. He H; Di Y; Liang M; Yang F; Yao L; Hao S; Li J; Jiang Y; Jin C; Fu D Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161 [TBL] [Abstract][Full Text] [Related]
10. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma. Castilla MÁ; Moreno-Bueno G; Romero-Pérez L; Van De Vijver K; Biscuola M; López-García MÁ; Prat J; Matías-Guiu X; Cano A; Oliva E; Palacios J J Pathol; 2011 Jan; 223(1):72-80. PubMed ID: 21125666 [TBL] [Abstract][Full Text] [Related]
11. A genome-wide investigation of microRNA expression identifies biologically-meaningful microRNAs that distinguish between high-risk and low-risk intraductal papillary mucinous neoplasms of the pancreas. Permuth-Wey J; Chen YA; Fisher K; McCarthy S; Qu X; Lloyd MC; Kasprzak A; Fournier M; Williams VL; Ghia KM; Yoder SJ; Hall L; Georgeades C; Olaoye F; Husain K; Springett GM; Chen DT; Yeatman T; Centeno BA; Klapman J; Coppola D; Malafa M PLoS One; 2015; 10(1):e0116869. PubMed ID: 25607660 [TBL] [Abstract][Full Text] [Related]
12. MiR-10a in Pancreatic Juice as a Biomarker for Invasive Intraductal Papillary Mucinous Neoplasm by miRNA Sequencing. Kuratomi N; Takano S; Fukasawa M; Maekawa S; Kadokura M; Shindo H; Takahashi E; Hirose S; Fukasawa Y; Kawakami S; Hayakawa H; Takada H; Nakakuki N; Kato R; Yamaguchi T; Nakayama Y; Kawaida H; Kono H; Inoue T; Kondo T; Ichikawa D; Enomoto N Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809988 [TBL] [Abstract][Full Text] [Related]
13. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer. Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864 [TBL] [Abstract][Full Text] [Related]
14. hsa-miR-96 and hsa-miR-217 Expression Down-Regulates with Increasing Dysplasia in Pancreatic Intraepithelial Neoplasias and Intraductal Papillary Mucinous Neoplasms. Chang X; Yu C; Li J; Yu S; Chen J Int J Med Sci; 2017; 14(5):412-418. PubMed ID: 28539816 [No Abstract] [Full Text] [Related]
15. Liver-intestine cadherin expression is associated with intestinal differentiation and carcinogenesis in intraductal papillary mucinous neoplasm. Morimatsu K; Aishima S; Kayashima T; Hayashi A; Nakata K; Oda Y; Taguchi T; Tsuneyoshi M; Tanaka M; Oda Y Pathobiology; 2012; 79(2):107-14. PubMed ID: 22286087 [TBL] [Abstract][Full Text] [Related]
16. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma. Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881 [TBL] [Abstract][Full Text] [Related]
17. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant. Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889 [TBL] [Abstract][Full Text] [Related]
18. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition. Ma Y; Zheng X; Zhou J; Zhang Y; Chen K Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850 [TBL] [Abstract][Full Text] [Related]
19. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice. Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868 [TBL] [Abstract][Full Text] [Related]
20. Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma. Kohler I; Bronsert P; Timme S; Werner M; Brabletz T; Hopt UT; Schilling O; Bausch D; Keck T; Wellner UF J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():78-84. PubMed ID: 25827809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]